RESUMO
The authors wish to state that in the above article, one of the authors (Marwan Akel) was excluded inadvertently during the peer review stage. The corrected author group read as follows.Souheil Hallit1,2,*, Rouba Karen Zeidan2,3, Sylvia Saade4, Aline Hajj5,6, Rabih Hallit1, Marwan Akel2,4, Charbel Yahchouchy3, Nelly Kheir7, Katia Iskandar8, Hala Sacre2,9, Pascale Salameh2,10,11.
RESUMO
Inclusion of a pharmacist showed that pharmacy-led patient education can positively impact treatment outcome, chronic obstructive pulmonary disease (COPD) knowledge, medication adherence, quality of life, significant reduction in hospital admission rates, and emergency department visits. The objectives were to assess the degree of COPD knowledge in Lebanese community pharmacists as well as their attitudes and practice toward disease management. Between January and May 2018, a cross-sectional survey enrolled 709 Lebanese community pharmacists. A committee was created to build up the questionnaire; it was composed of two physicians (one infectious disease specialist and one pulmonologist) and eight pharmacists, with long expertise in community and hospital pharmacy. It comprised 12 questions assessing knowledge, 12 questions for attitude, and 13 questions for practice. Higher attitude (ß = 0.56) and higher practice (ß = 0.41) were associated with higher knowledge score. Higher knowledge (ß = 0.10) and practice (ß = 0.16) scores as well as female gender (ß = 0.60) were significantly associated with higher attitude scores. Higher knowledge (ß = 0.13) and higher attitude (ß = 0.19) showed significant association with higher practice scores. Female gender (ß = -0.94), however, was significantly associated with decreased practice score. Our study highlights the importance of assessing the capabilities of pharmacists of achieving their support role in COPD patients. In order to improve community pharmacists' knowledge of COPD, ultimately improving patient outcomes, further education is crucial.
